Business Context and Reporting Period
This Form 8-K filing by Pavmed Inc. (Delaware) was submitted on October 12, 2016, reporting events occurring on that date. The filing focuses on corporate governance and executive compensation arrangements rather than periodic financial performance.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to a specific executive compensation agreement:
- Monthly Retainer: $12,500
- One-time Execution Fee: $37,500
Material Changes
On October 12, 2016, the Company entered into a Consulting Agreement with Michael Glennon, its Vice Chairman, effective October 1, 2016. This represents a new contractual obligation and compensation arrangement for a senior officer.
Outlook, Risks, and Management Commentary
Scope of Services: Mr. Glennon will advise on the development and commercialization of medical device products, including interfacing with contract manufacturers, supply chain development, and establishing commercialization channels with distributors and partners.
Termination Terms: The agreement may be terminated by either party with 30 days' prior written notice. Immediate termination is permitted for cause (including material breach) or if Mr. Glennon is employed on a full-time basis.
Legal Provisions: The agreement includes covenants protecting confidential information and a mutual indemnity provision for claims arising from the services.
Investor Verification Checklist
- Verify the total cash outflow impact of the $37,500 execution fee and the recurring $12,500 monthly retainer against the company's current cash position.
- Confirm whether Mr. Glennon's role as Vice Chairman is being supplemented or replaced by this consulting arrangement.
- Review the attached Exhibit 10.1 for specific definitions of "cause" and any non-compete or intellectual property clauses not summarized in the text.
- Assess the strategic importance of the supply chain and distributor channels Mr. Glennon is tasked with developing relative to the company's product pipeline.